• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.铁和铜在帕金森病发病机制中的作用
Indian J Clin Biochem. 2017 Jul;32(3):353-356. doi: 10.1007/s12291-016-0614-5. Epub 2016 Sep 3.
2
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.帕金森病及其他影响基底神经节的神经退行性疾病中铁、铁蛋白和其他微量金属水平的变化。
Brain. 1991 Aug;114 ( Pt 4):1953-75. doi: 10.1093/brain/114.4.1953.
3
The role of zinc, copper, manganese and iron in neurodegenerative diseases.锌、铜、锰和铁在神经退行性疾病中的作用。
Neurotoxicology. 2019 Sep;74:230-241. doi: 10.1016/j.neuro.2019.07.007. Epub 2019 Aug 1.
4
Role of heavy metals (copper (Cu), arsenic (As), cadmium (Cd), iron (Fe) and lithium (Li)) induced neurotoxicity.重金属(铜(Cu)、砷(As)、镉(Cd)、铁(Fe)和锂(Li))诱导的神经毒性作用。
Chemosphere. 2022 Aug;301:134625. doi: 10.1016/j.chemosphere.2022.134625. Epub 2022 Apr 16.
5
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.植物环烯醚萜类化合物在阿尔茨海默病和帕金森病中的治疗潜力:综述。
Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8.
6
[Ceruloplasmin (Cp) and iron in connection with Parkinson's disease (PD) and Alzheimer's disease (AD)].[铜蓝蛋白(Cp)与铁和帕金森病(PD)及阿尔茨海默病(AD)的关系]
Laeknabladid. 2012 Oct;98(10):531-7. doi: 10.17992/lbl.2012.10.457.
7
Ceruloplasmin and iron in Alzheimer's disease and Parkinson's disease: a synopsis of recent studies.载脂蛋白 E 基因型与阿尔茨海默病和帕金森病的关联:系统综述和荟萃分析
Neuropsychiatr Dis Treat. 2012;8:515-21. doi: 10.2147/NDT.S34729. Epub 2012 Nov 2.
8
Copper and copper proteins in Parkinson's disease.帕金森病中的铜与铜蛋白
Oxid Med Cell Longev. 2014;2014:147251. doi: 10.1155/2014/147251. Epub 2014 Jan 8.
9
Induction of ferroxidase enzymatic activity by copper reduces MPP+-evoked neurotoxicity in rats.铜诱导的亚铁氧化酶活性降低了 MPP+诱导的大鼠神经毒性。
Neurosci Res. 2013 Mar;75(3):250-5. doi: 10.1016/j.neures.2012.12.003. Epub 2013 Jan 5.
10
Is Parkinson's disease the heterozygote form of Wilson's disease: PD = 1/2 WD?帕金森病是威尔逊病的杂合子形式吗:帕金森病 = 1/2 威尔逊病?
Med Hypotheses. 2001 Feb;56(2):171-3. doi: 10.1054/mehy.2000.1134.

引用本文的文献

1
Iron mishandling in the brain and periphery in Parkinson's disease.帕金森病中大脑和外周铁处理不当
NPJ Parkinsons Dis. 2025 Aug 18;11(1):246. doi: 10.1038/s41531-025-01089-7.
2
Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds.铜在神经退行性疾病中的作用及天然化合物的治疗潜力洞察
Curr Neuropharmacol. 2024;22(10):1650-1671. doi: 10.2174/1570159X22666231103085859.
3
Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson's Phenotype Development.与帕金森病表型发展风险升高相关的铜状态异常。
Antioxidants (Basel). 2023 Aug 22;12(9):1654. doi: 10.3390/antiox12091654.
4
Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View.神经退行性疾病中的生化与分子途径:综合视角
Cells. 2023 Sep 20;12(18):2318. doi: 10.3390/cells12182318.
5
Are high copper levels related to Alzheimer's and Parkinson's diseases? A systematic review and meta-analysis of articles published between 2011 and 2022.高铜水平与阿尔茨海默病和帕金森病有关吗?对 2011 年至 2022 年发表的文章进行的系统评价和荟萃分析。
Biometals. 2024 Feb;37(1):3-22. doi: 10.1007/s10534-023-00530-9. Epub 2023 Aug 18.
6
Metal Exposure and Risk of Parkinson Disease: A Systematic Review and Meta-Analysis.金属暴露与帕金森病风险:系统评价和荟萃分析。
Am J Epidemiol. 2023 Jul 7;192(7):1207-1223. doi: 10.1093/aje/kwad082.
7
Platinum-Based Interdigitated Micro-Electrode Arrays for Reagent-Free Detection of Copper.基于铂的叉指微电极阵列用于无试剂检测铜。
Sensors (Basel). 2021 May 19;21(10):3544. doi: 10.3390/s21103544.
8
Interdependence of metals and its binding proteins in Parkinson's disease for diagnosis.帕金森病中金属及其结合蛋白在诊断方面的相互依赖性
NPJ Parkinsons Dis. 2021 Jan 4;7(1):3. doi: 10.1038/s41531-020-00146-7.
9
Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation.帕金森病中的氧化应激:抗氧化补充剂的潜在益处。
Oxid Med Cell Longev. 2020 Oct 12;2020:2360872. doi: 10.1155/2020/2360872. eCollection 2020.
10
Elemental quantification and analysis of structural abnormalities in neurons from Parkinson's-diseased brains by X-ray fluorescence microscopy and diffraction.通过X射线荧光显微镜和衍射对帕金森病大脑神经元中的元素进行定量分析及结构异常研究。
Biomed Opt Express. 2020 Jun 2;11(7):3423-3443. doi: 10.1364/BOE.389408. eCollection 2020 Jul 1.

本文引用的文献

1
Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson's disease.评估帕金森病患者血浆中硒、铜、铁和锌的水平。
PLoS One. 2013 Dec 10;8(12):e83060. doi: 10.1371/journal.pone.0083060. eCollection 2013.
2
Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study.血清铁水平与帕金森病风险:一项孟德尔随机化研究。
PLoS Med. 2013;10(6):e1001462. doi: 10.1371/journal.pmed.1001462. Epub 2013 Jun 4.
3
Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson's disease patients: a pilot study.血浆铜蓝蛋白氧化酶活性与帕金森病患者黑质超声面积相关:一项初步研究。
Neurochem Res. 2011 Nov;36(11):2111-5. doi: 10.1007/s11064-011-0535-x. Epub 2011 Jun 26.
4
Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.血清铜蓝蛋白水平降低特征性地加重帕金森病患者的黑质铁沉积。
Brain. 2011 Jan;134(Pt 1):50-8. doi: 10.1093/brain/awq319. Epub 2010 Nov 24.
5
Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review.神经退行性疾病中铜蓝蛋白和超氧化物歧化酶 1(SOD1)的病例对照研究:简短综述。
J Neurol Sci. 2010 Dec 15;299(1-2):51-4. doi: 10.1016/j.jns.2010.08.047. Epub 2010 Sep 18.
6
Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.铜、铜蓝蛋白和金属硫蛋白在人类神经退行性疾病患者及其一级亲属中的临床应用。
Brain Res. 2010 Mar 10;1319:118-30. doi: 10.1016/j.brainres.2009.11.085. Epub 2009 Dec 22.
7
Individual dopaminergic neurons show raised iron levels in Parkinson disease.在帕金森病中,单个多巴胺能神经元显示出铁水平升高。
Neurology. 2007 May 22;68(21):1820-5. doi: 10.1212/01.wnl.0000262033.01945.9a.
8
Serum trace element levels and the complexity of inter-element relations in patients with Parkinson's disease.帕金森病患者的血清微量元素水平及元素间关系的复杂性
J Trace Elem Med Biol. 2004;18(2):163-71. doi: 10.1016/j.jtemb.2004.09.003.
9
Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions.用于中枢神经系统疾病的新型螯合剂,这些疾病涉及铁和其他金属离子代谢的改变。
Ann N Y Acad Sci. 2004 Mar;1012:326-41. doi: 10.1196/annals.1306.026.
10
The relevance of iron in the pathogenesis of Parkinson's disease.铁在帕金森病发病机制中的相关性。
Ann N Y Acad Sci. 2004 Mar;1012:193-208. doi: 10.1196/annals.1306.017.

铁和铜在帕金森病发病机制中的作用

Role of Iron and Copper in the Pathogenesis of Parkinson's Disease.

作者信息

Gangania Mohit Kumar, Batra Jyoti, Kushwaha Suman, Agarwal Rachna

机构信息

Department of Biochemistry, Santosh University, NCR, Delhi, India.

Department of Neurology, Institute of Human Behaviour and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India.

出版信息

Indian J Clin Biochem. 2017 Jul;32(3):353-356. doi: 10.1007/s12291-016-0614-5. Epub 2016 Sep 3.

DOI:10.1007/s12291-016-0614-5
PMID:28811697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5539009/
Abstract

Parkinson's disease (PD) is an old age disorder of basal ganglia which involves oligomerization of α-synuclein protein and formation of intercellular inclusions known as "Lewy bodies" in substantia nigra and caudate nuclei in brain which is progressive in nature. It is second most prevalent neurodegenerative disorder characterized by tremor at rest, muscle rigidity, slowness of movement (bradykinesia, akinesia), and changes in posture (instability). Both excess and deficiency in levels of transition metals (especially iron, copper) can be detrimental to the central nervous system. Abnormalities in iron (Fe) and copper (Cu) metabolism have been reported to produce oxidative stress which is one of the major cause in pathogenesis of PD. In the present study 35 PD patients and 33 controls of Northern Indian population were included and serum levels of Fe, Cu and ceruloplasmin (Cp) were measured. Serum Fe ( < 0.01) and Cu ( < 0.01) levels were found to be significantly decreased in PD, whereas there was no significant change in Cp levels in PD patients as compared to controls. These results suggest the existence of a defect in iron which over the time, may hasten the entry of iron into the brain and decrease iron in the extracellular compartment in PD patients.

摘要

帕金森病(PD)是一种基底神经节的老年疾病,它涉及α-突触核蛋白的寡聚化以及在大脑黑质和尾状核中形成称为“路易小体”的细胞内包涵体,这种疾病具有进行性。它是第二常见的神经退行性疾病,其特征为静止性震颤、肌肉僵硬、运动迟缓(运动徐缓、运动不能)和姿势改变(不稳定)。过渡金属(尤其是铁、铜)水平过高或过低都可能对中枢神经系统有害。据报道,铁(Fe)和铜(Cu)代谢异常会产生氧化应激,这是帕金森病发病机制的主要原因之一。在本研究中,纳入了35名印度北部人群的帕金森病患者和33名对照者,并测量了血清中铁、铜和铜蓝蛋白(Cp)的水平。发现帕金森病患者的血清铁(<0.01)和铜(<0.01)水平显著降低,而与对照组相比,帕金森病患者的铜蓝蛋白水平没有显著变化。这些结果表明存在铁代谢缺陷,随着时间的推移,可能会加速铁进入大脑,并降低帕金森病患者细胞外间隙中的铁含量。